Analysis of Clinical Trials of New Drugs for Liver Diseases in China
Longfei Lin, Hui Li Institute Chinese materia medica china academy of Chinese medical sciences, Beijing, People's Republic of ChinaCorrespondence: Hui LiInstitute Chinese materia medica china academy of Chinese medical sciences, Dongcheng District Dongzhimen Nanxiaojie Within 16, Beijing, Peopl...
Saved in:
Main Authors: | Lin L (Author), Li H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of Suspension of Clinical Trials for Drug Registration in China
by: Xian Su, et al.
Published: (2021) -
Changes in Drug Clinical Trials of Thyroid Diseases in China, 2009–2022
by: Li C, et al.
Published: (2023) -
The Success Rate of New Drug Development in Clinical Trials: Crohn's Disease
by: Jayson Lee Parker, et al.
Published: (2010) -
Clinical and Genetic Spectra of Inherited Liver Disease in Children in China
by: Youhong Fang, et al.
Published: (2021) -
Current situation of pediatric clinical trials in China: focus on trials for drug marketing application and administrative approval
by: Lin Song, et al.
Published: (2022)